Soft gelatin capsules, also known as softgels or soft elastic capsules, are capsules that dissolve faster than hard gelatin capsules and are used to carry medicine in liquid or powder form. It is used to deliver pharmaceuticals and a variety of nutritional supplements, including omega-3 fish oils.
The main types of soft gel capsules are gelatin or animal-based, and non-animal based. Gelatin or animal-based refers to cattle and pig connective tissues, boiling, broken bones, and decomposing animal hides that are used to make gelatin. The various manufacturers are pharmaceutical companies, nutraceutical companies, cosmeceutical companies, contract manufacturing organizations, and manufacturers of softgel capsules that are used in antacid and anti-flatulent preparations, anti-anemic preparations, anti-inflammatory drugs, antibiotics, and antibacterial drugs, cough and cold preparations, health supplements, vitamin D dietary supplements, and pregnancy.
The soft-gel capsules market research report is one of a series of new reports from The Business Research Company that provides soft-gel capsules market statistics, including soft-gel capsules industry global market size, regional shares, competitors with a soft-gel capsules market share, detailed soft-gel capsules market segments, market trends and opportunities, and any further data you may need to thrive in the soft-gel capsules industry. This soft-gel capsule market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The global softgel capsules market size is expected to grow from $7.20 billion in 2022 to $7.75 billion in 2023 at a compound annual growth rate (CAGR) of 7.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The softgel capsules market is expected to grow to $10.27 billion in 2027 at a CAGR of 7.3%.
The rising prevalence of chronic ailments such as cardiovascular diseases is expected to drive the growth of the soft gel capsules market going forward. Chronic diseases refer to ailments that persist for a year or longer, such as cancer, heart disease, stroke, diabetes, cancer, and arthritis. These are the most common chronic illnesses, which can be controlled but not cured and require ongoing nutrition and medical care. Soft gel capsules provide the nutritional supplements required for chronic patients; as a result, the rising prevalence of chronic ailments increases the demand for soft gel capsules. For instance, in September 2020, according to a study report issued by the American Action Forum, chronic illness frequency and expenses are increasing in the United States. Chronic illness is anticipated to continue increasing as the incidence of illness among children and young people increases. Chronic illness is a significant healthcare issue since it costs the US $3.7 trillion annually, or about 19.6% of the GDP, and is rising. Therefore, the rising prevalence of chronic ailments such as cardiovascular diseases will drive the soft gel capsules market.
Technological advancements are a key trend gaining popularity in the soft gel capsules market. Major companies operating in the soft gel capsules market are focused on developing new products with the latest technologies to sustain their position in the market. For instance, in November 2020, Roquette, a France-based provider of plant-based ingredients and pharmaceutical excipients, launched the pharmaceutical-grade solution LYCAGEL for a vegetarian soft gel capsule formulation developed with a pea starch technology. The new capsule formulation contains salt, NEOSORB sorbitol, a plant-based component utilized for nutraceutical purposes, and carrageenan, a setting agent found in marine macroalgae. The new product offers notable capsule strength, seal integrity, a short drying time without stickiness, quick disintegration, no cross-linking, and a processing temperature suitable for higher temperatures.
In August 2021, Catalent, Inc., a US-based provider of development sciences and manufacturer of medicines, acquired Bettera Holdings, LLC, for $1 billion. Through this acquisition, Catalent, Inc. expects to accelerate the growth of its global softgel and oral dose formulation and manufacturing businesses to provide consumer health innovators with unrivalled choice, formulation expertise, and high-quality, scalable manufacturing solutions to help bring new products to market. Bettera Holdings LLC is a US-based provider of consumer-preferred products for nutraceutical, functional, and botanical ingredients, including soft gel capsules.
Major players in the softgel capsules market are Catalent Inc., Eurocaps Ltd., Capsugel Healthcare Ltd., Aenova Group GmbH, Sirio Pharma Co. Ltd. (SIRIO), Procaps Laboratories, Captek Softgel International Inc., Fuji Capsule Co. Ltd., Hunan ER-KANG Pharmaceutical Co. Ltd., Patheon, Curtis Health Caps, Delpharm Evreux, Estrellas Life Sciences Pvt. Ltd., Elnova Pharma, and Soft Gel Technologies Inc.
North America was the largest region in the soft gel capsules market in 2022. The regions covered in the soft gel capsules report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
The countries covered in the soft gel capsules market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA.
The soft gel capsules market consists of sales of liquid or semisolid-filled capsules, chewables, suckers, twist-offs, and meltable capsules. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
The global softgel capsules market is segmented -
1) By Type: Gelatin or Animal Based, Non-Animal Based
2) By Manufacturers: Pharmaceutical Companies, Nutraceutical Companies, Cosmetic Companies, Contract Manufacturing Organizations, Softgel Capsules
3) By Application: Antacid And Anti-Flatulent Preparations, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic And Antibacterial Drugs, Cough And Cold Preparations, Health Supplement, Vitamin And Dietary Supplement, Pregnancy